Rationally designed less toxic SPD-304 analogs and preliminary evaluation of their TNF inhibitory effects.
Alexiou P, Papakyriakou A, Ntougkos E, Papaneophytou CP, Liepouri F, Mettou A, Katsoulis I, Maranti A, Tsiliouka K, Strongilos A, Chaitidou S, Douni E, Kontopidis G, Kollias G, Couladouros E, Eliopoulos E.
Alexiou P, et al. Among authors: eliopoulos e.
Arch Pharm (Weinheim). 2014 Nov;347(11):798-805. doi: 10.1002/ardp.201400198. Epub 2014 Aug 27.
Arch Pharm (Weinheim). 2014.
PMID: 25160057